Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News

Pharma News

Acne antibiotic delays development of multiple sclerosis in small trial
Acne antibiotic delays development of multiple sclerosis in small trial
(Reuters Health) - An inexpensive antibiotic used to fight acne appears to delay the development of multiple sclerosis in people in the earliest stage of the crippling disease, according to a ...
Scientists save beta cells from destruction in type 1 diabetes
Scientists save beta cells from destruction in type 1 diabetes
June 1 (UPI) -- Researchers at the Jackson Laboratory in Bar Harbor, Maine, have found a way to protect beta cells from destruction, which could lead to therapies to prevent type 1 diabetes.
FDA approves first Strattera generics from 4 companies
FDA approves first Strattera generics from 4 companies
SILVER SPRING, Md.
QuintilesIMS Institute examines technological, economic growth in global oncology
QuintilesIMS Institute examines technological, economic growth in global oncology
DANBURRY, Conn.
Teva's migraine drug clears late-stage study
Teva's migraine drug clears late-stage study
Teva Pharmaceutical Industries Ltd said on Wednesday its experimental drug to prevent migraine cleared a late-stage study, paving the way for a U.
Statins associated with improved heart structure and function
Statins associated with improved heart structure and function
Prague, Czech Republic – 26 May 2017.
Meningococcal Group B vaccine, Trumenba, gets approval in Europe
Meningococcal Group B vaccine, Trumenba, gets approval in Europe
Pfizer Inc.
New Antibiotic Packs a Punch Against Bacterial Resistance
New Antibiotic Packs a Punch Against Bacterial Resistance
LA JOLLA, CA – May 29, 2017 – Scientists at The Scripps Research Institute (TSRI) have given new superpowers to a lifesaving antibiotic called vancomycin, an advance that could eliminate t...
Century-old drug may provide hope for autistic kids
Century-old drug may provide hope for autistic kids
Administering a single dose of 100-year-old drug suramin -- originally developed to treat African sleeping sickness -- can improve symptoms of autism spectrum disorder (ASD) in children, a stu...
World No Tobacco Day 2017: Beating tobacco for health, prosperity, the environment and national development
World No Tobacco Day 2017: Beating tobacco for health, prosperity, the environment and national development
30 May 2017 | Geneva - Action to stamp out tobacco use can help countries prevent millions of people falling ill and dying from tobacco-related disease, combat poverty and, according to a first-ever W...
Novartis has assets to sell, investors wary of what it might buy
Novartis has assets to sell, investors wary of what it might buy
As Novartis (NOVN.
Glenmark obtained FDA approval for hypertension drug
Glenmark obtained FDA approval for hypertension drug
Glenmark Pharmaceuticals stated in a regulatory filing that it received final FDA approval for its generic version of Forest Laboratories’ hypertension treatment Bystolic (nebivolol).
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand